-- Days : -- HRS : -- MIN : -- SEC

Register Now →

Subscribe

News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Opinion|Videos|December 21, 2023

Unmet Needs and Treatment Approaches in Newly Diagnosed Multiple Myeloma

Episodes in this series

EP. 1 Unmet Needs and Treatment Approaches in Newly Diagnosed Multiple Myeloma

EP. 1 Unmet Needs and Treatment Approaches in Newly Diagnosed Multiple Myeloma

Video 2 - "ASH 2023: PERSEUS Trial Overview"

EP. 2 ASH 2023: PERSEUS Trial Overview

Video 3 - "Considerations for Combination Therapy and MRD Testing in Newly Diagnosed Multiple Myeloma Patients"

EP. 3 Considerations for Combination Therapy and MRD Testing in Newly Diagnosed Multiple Myeloma Patients

Video 4 - "ASH 2023: Analyzing IsKia Trial"

EP. 4 ASH 2023: Analyzing IsKia Trial

Video 5 - "Examining Data from MonumenTAL-2 Study"

EP. 5 Examining Data from MonumenTAL-2 Study

Video 6 - "Optimizing Bispecific Use in Multiple Myeloma Treatment"

EP. 6 Optimizing Bispecific Use in Multiple Myeloma Treatment

Video 7 - "Navigating Impact of RRMM Treatment on Patient Quality of Life"

EP. 7 Navigating Impact of RRMM Treatment on Patient Quality of Life

Video 8 - "Key RRMM-Related Takeaways from ASH 2023"

EP. 8 Key RRMM-Related Takeaways from ASH 2023

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Experts featured in this series.

The Right Fit First: How Psychiatrists Approach Initial Treatment and Patient Adherence

ByPatrick Runnels, MD, MBA,Ginger Shupe, MD,Gus Alva, MD, DFAPA,Joe Goldberg, MD

Published: June 23rd 2026 | Updated: June 16th 2026

Experts featured in this series.

Formulary Frustrations: How Insurance Constraints Shape Psychiatric Treatment Decisions

ByPatrick Runnels, MD, MBA,Ginger Shupe, MD,Gus Alva, MD, DFAPA,Joe Goldberg, MD

Published: June 23rd 2026 | Updated: June 16th 2026

Navigating the Human Side of Extrapulmonary Neuroendocrine Carcinoma: Patient Burden and Caregiver Support

ByRyan Haumschild, PharmD, MBA,William K. Oh, MD,Aman Chauhan, MD,Namrata Vijayvergia, MD,Sandy Kotiah, MD

June 22nd 2026

The 5-Year Horizon: Evolving Paradigms in Ischemic Stroke Management

ByMark Makhinson, PharmD, MBA,Andrew Russman, DO, FAHA, FAAN,Danison Emmerson, MD,David Z. Rose, MD

June 22nd 2026

Closing the Gap: Underrecognition and the Critical Need for Early Diagnosis in Extrapulmonary Neuroendocrine Carcinoma

ByRyan Haumschild, PharmD, MBA,William K. Oh, MD,Aman Chauhan, MD,Namrata Vijayvergia, MD,Sandy Kotiah, MD

June 22nd 2026

Trending on AJMC

ATTR-CM Incidence, Prevalence Rose Sharply in the US

CDC Officially Ends Hantavirus Response as Outbreak Risk Recedes

Mixed Phase 3 Results for IB6-Targeting ADC Raise Questions on Optimal Use in NSCLC

First Generic of Priftin Approved by FDA for Tuberculosis Treatment and Prevention

Natera's Moshkevich Discusses TOMR Approach and the Future of MRD-Guided Care